In this interview, David Engel from Full Moon Investments in the U.S., charts the firm’s successful targeted investment strategy – informed by industry-leading experience and expertise – including comments on the CBD hemp and medical cannabis space.
Jennifer Kay and Bevin Engelward walk us through how the National Institutes of Health teams up with universities to tackle some of the most chemically contaminated sites in the United States.
This chemistry focus delves into making nanocellulose filters for water purification with underutilised biomass, as described here by Benjamin Hsiao from Stony Brook University in the U.S.
Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.
Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.
Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
Dr Frank Wuest, Professor at Department of Oncology - University of Alberta, sheds light on the imaging biomarkers and the Alberta Radiopharmaceutical Collaboration in this special oncology focus.
Richard Teague, from Rangeland, Wildlife and Fisheries Management, Texas A&M University, provides more insight into sustainable agroecosystems, focussing on cropping using regenerative agricultural principles.
The Division of Chemistry at the National Science Foundation, provides an update on their work in driving discovery and development concerning chemistry research that improves the quality of life in the United States.
Mayank Kejriwal from the University of Southern California, discusses the role innovative technology can play when it comes to natural disasters and other crises.
In this article, our thoughts are directed towards understanding the Canadian Institutions of Health Research (CIHR) and The Institute of Nutrition, Metabolism and Diabetes (INMD).
Kapil Bharti, PhD, Senior Investigator and Head of the Ocular and Stem Cell Translational Research Section at the National Eye Institute (NEI), explains testing the safety of a stem cell therapy for age-related macular degeneration in this special focus on eye health.
